Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet inhibition and/or lipid lowering in non-ACS patients with elevated high-sensitivity troponin
2019-002833-12Phase 3Terminated
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Oct 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin and atorvastatin in cardiac ischemia, myocardial infarction (MI) and coronary arteriosclerosis (4 arms), sponsored by University Medical Center Hamburg-Eppendorf. Started Oct 2019; status: terminated.
02
Drugs
aspirinatorvastatin
03
Conditions
cardiac ischemiamyocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on 2019-002833-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002833-12.